Frank Rimerman Advisors LLC Takes $286,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Frank Rimerman Advisors LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 481 shares of the biotechnology company's stock, valued at approximately $286,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Groupama Asset Managment acquired a new position in shares of Axon Enterprise during the 3rd quarter valued at $200,000. Massachusetts Financial Services Co. MA acquired a new position in Axon Enterprise during the third quarter worth about $120,553,000. Proficio Capital Partners LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at about $78,414,000. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock worth $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its holdings in shares of Axon Enterprise by 328.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company's stock valued at $86,354,000 after acquiring an additional 111,405 shares during the period. Institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,035 shares of the company's stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the sale, the insider now directly owns 124,243 shares of the company's stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,792 shares of company stock valued at $1,087,843 over the last quarter. Insiders own 5.70% of the company's stock.

Remove Ads

Axon Enterprise Stock Up 0.3 %

NASDAQ:AXON traded up $1.59 during trading hours on Friday, reaching $560.00. The company's stock had a trading volume of 802,199 shares, compared to its average volume of 844,921. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $42.91 billion, a price-to-earnings ratio of 144.70, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The business's 50-day moving average is $592.10 and its 200-day moving average is $539.60.

Analysts Set New Price Targets

A number of research firms have recently issued reports on AXON. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Needham & Company LLC restated a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Finally, Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.